These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3103344)
1. [rt-PA in acute myocardial infarct, randomized studies in Europe and the USA]. von Essen R Z Kardiol; 1986; 75 Suppl 5():101-6. PubMed ID: 3103344 [TBL] [Abstract][Full Text] [Related]
2. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]. Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339 [TBL] [Abstract][Full Text] [Related]
3. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]. Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348 [TBL] [Abstract][Full Text] [Related]
4. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [TBL] [Abstract][Full Text] [Related]
5. New developments in thrombolytic therapy. Collen D; Gold HK Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261 [TBL] [Abstract][Full Text] [Related]
6. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
7. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
8. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction. Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525 [TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy in acute myocardial infarct]. von Essen R Z Gesamte Inn Med; 1987 Sep; 42(17):486-91. PubMed ID: 3120430 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction. Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408 [TBL] [Abstract][Full Text] [Related]
12. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction. Parise P; Hauert J; Iorio A; Callegari P; Agnelli G J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212 [TBL] [Abstract][Full Text] [Related]
13. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct]. Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040 [TBL] [Abstract][Full Text] [Related]
15. Primary intracoronary stenting in comparison with intravenous rt-PA thrombolysis plus rescue intracoronary intervention in patients with acute myocardial infarction. Zhang D; Cai X; Zhang R; Zhang J; Shen W Chin Med J (Engl); 2002 Feb; 115(2):163-5. PubMed ID: 11940322 [TBL] [Abstract][Full Text] [Related]
16. Effects of thrombolytic agents on coronary recanalization and patency, cardiac enzyme release, left ventricular function, and mortality in patients with acute myocardial infarction. Verstraete M J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S38-48. PubMed ID: 2483231 [TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator: a new thrombolytic agent. Crabbe SJ; Cloninger CC Clin Pharm; 1987 May; 6(5):373-86. PubMed ID: 3117481 [TBL] [Abstract][Full Text] [Related]
18. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction. Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428 [TBL] [Abstract][Full Text] [Related]
19. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Dalen JE; Gore JM; Braunwald E; Borer J; Goldberg RJ; Passamani ER; Forman S; Knatterud G Am J Cardiol; 1988 Aug; 62(4):179-85. PubMed ID: 3135737 [TBL] [Abstract][Full Text] [Related]
20. [New substances and dosages for thrombolysis in acute myocardial infarct]. Zeymer U; Neuhaus KL Z Kardiol; 1993; 82 Suppl 2():137-41. PubMed ID: 8328192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]